Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips : introduces next-generation Digital Pathology Suite - IntelliSite - to enhance diagnostic confidence and streamline pathology lab workflows

10/15/2021 | 04:00am EST

October 15, 2021

  • Solution offers high quality imaging with multi-site, multi-disciplinary interoperability, artificial intelligence and Laboratory Information System integration, enhancing diagnostic confidence
  • Scalable image management system caters to the needs of all levels of pathology imaging

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its next-generation digital pathology solution, moving digital pathology into the heart of enterprise-wide healthcare informatics. Philips Digital Pathology Suite – IntelliSite – features a comprehensive, scalable suite of software tools and capabilities designed to help streamline workflows, enhance diagnostic confidence, facilitate team collaboration, integrate artificial intelligence (AI) and increase the efficiency of pathology labs.

Philips Digital Pathology Suite offers a range of solutions designed for different use cases with an affordable cost of ownership. From low-volume ‘spoke’ labs or small independent labs, where small batches of slides are continually processed and scanned, to medium and large labs operating high-volume batch processing workflows. The hardware is also pre-equipped for multi-layer slide scanning. Images are captured in a centralized informatics platform that has been optimized around pathologists’ workflows, integrating with leading third-party AI tools and algorithms with the aim to further reduce laboratory costs and enhance diagnostic capabilities.

"Integrated diagnostic capabilities are a cornerstone to a precise diagnosis and personalized care pathway selection for oncology patients and only when data and specialties work together in harmony can the ultimate promise of care be realized,” said Louis Culot, General Manager Oncology Informatics at Philips. “That’s why bringing together multiple pieces of the healthcare continuum – like radiology, pathology, and genomics – is the key to a new paradigm of diagnostic precision. By providing pathologists the interoperability and connectivity to share high-quality images and diagnostic insights across networks, Philips Digital Pathology Suite positions them as key stakeholders in the data-driven healthcare systems of the future.”

Digital Pathology Suite includes a range of three pathology slide scanners, as well as Pathology Workspace – Image Management System – a comprehensive set of software tools and capabilities that encompass every stage of the digital pathology process, including an advanced image management system, bidirectional interoperability into laboratory information systems, and a case viewer that facilitates multidisciplinary case reviews and care pathway selection. Diagnostic confidence is enhanced by superb image quality and advanced algorithms, such as automatic tissue shape detection and non-rectangular optimization of regions of interest. Vendor-agnostic data interoperability also allows the easy sharing of patient-centric histology data across enterprises and between sites.

“MEDIPATH is focused on accelerating the path of augmented pathology by slide digitalization on all our technical platforms. We are very excited to leverage the new Philips Digital Pathology Suite, including the Pathology Scanner SG300 and Pathology Workspace with de-identification tools, for each of our sites,” said Stephane Rossat, Director for innovation, science and project management at MEDIPATH, a French Pathology group with a network of 11 technical labs. “Following the first days of installation, the solution is already proving easy to use, with images generated more quickly, while the quality and sharpness of the images produced is experienced to be superior. The Philips Digital Pathology Suite is the solution that our organization needs to expand our digital pathology capabilities and activate our transformation [1].”

Integrated intelligence and automation across smart diagnostic systems
Precision medicine has increased the volume and complexity of workloads, with pathology labs worldwide facing a shortage of skilled staff. Within the diagnosis and staging of cancer, pathology information is combined with data from multiple disciplines, including radiology, pathology and genomics, to deliver the diagnostic precision required for highly personalized care. There is an urgent need for solutions that combine operational efficiency, team-working, expertise sharing, and enterprise-wide informatics to make the most of a pathology lab’s human resources.

Through breakthrough innovations and partnerships, Philips integrates intelligence and automation into its Precision Diagnosis portfolio, including smart diagnostic systems, integrated workflow solutions with the aim to transform departmental operations, advanced informatics that enhance diagnostic confidence, and care pathway solutions that allow medical professionals to tailor treatment to individual patients. By developing and integrating AI-enabled applications, the company aims to enhance the ability to turn data into actionable insights and drive the right care in the right sequence at the right time.

Philips Digital Pathology Suite is being showcased at the Pathology Visions 2021 event (October 17-19, Las Vegas, USA). Follow @PhilipsLiveFrom for updates on Philips participation at the event, and visit Philips Digital Pathology for more information.   

[1] Results of customer testimonies are not predictive of results in other cases. Results in other cases may vary.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel.: +31 631 639 916
E-mail: mark.groves@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

  • Philips Digital Pathology Suite
  • Philips Pathology Scanner

Primary Logo

Source: Royal Philips

2021 GlobeNewswire, Inc., source Press Releases

All news about PHILIPS NV
05:12aPHILIPS : Periodic update on transaction details related to Philips' share repurchases
PU
12/02European ADRs Move Higher in Thursday Trading
MT
12/02Philips expands Augmented Reality Surgical Navigation - ClarifEye - to two new internat..
AQ
12/01Royal Philips' Surgical Navigation Solution Successfully Treats Two Patients In Spain, ..
MT
12/01PHILIPS NV : Deutsche Bank sticks Neutral
MD
12/01Philips expands Augmented Reality Surgical Navigation – ClarifEye – to two ..
AQ
12/01Philips Expands Augmented Reality Surgical Navigation ? Clarifeye ? to Two New Internat..
CI
11/29Philips extends AI-enabled CT imaging portfolio at RSNA 2021
AQ
11/29Periodic update on transaction details related to Philips' share repurchases
AQ
11/28Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and sca..
AQ
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 535 M 19 796 M 19 796 M
Net income 2021 3 567 M 4 027 M 4 027 M
Net Debt 2021 4 199 M 4 741 M 4 741 M
P/E ratio 2021 7,08x
Yield 2021 2,92%
Capitalization 27 899 M 31 549 M 31 495 M
EV / Sales 2021 1,83x
EV / Sales 2022 1,70x
Nbr of Employees 77 084
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 31,09 €
Average target price 45,15 €
Spread / Average Target 45,3%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-29.00%31 549
THERMO FISHER SCIENTIFIC34.43%247 297
DANAHER CORPORATION42.28%225 849
INTUITIVE SURGICAL, INC.20.03%116 931
SIEMENS HEALTHINEERS AG52.50%81 212
EDWARDS LIFESCIENCES CORPORATION20.38%68 564